twitter autopublish 5 twitter autopublish 5 twitter autopublish 5 twitter autopublish 5 twitter autopublish 5
The group has developed a breakthrough process that converts a high-octane fuel called...
The company builds low-emission, clean-energy microturbine technology for consumer and...
The parks connect directly to national power grids on long-term, fixed price government supply...
With Donald Trump, you never quite know what’s going to happen next.
The company controls 150,000 net acres, with over 230 (net to Point Loma) drilling opportunities...
Thrombo Therapeutics Inc Dr Michael Chapman sat down with Proactive at the 2019 BIO Investor Forum. The privately-held company is focused on treating traumatic injuries with its fast-acting diagnostic. Chapman indicated the company is 'shovel-ready' for a pivotal trial.
Get our market previews and stories before the main networks.
Not just the FTSE. Read about
opportunities from the whole
Hear directors at first-hand
or meet them in person at our events.
Watch IPOs and access on the same terms as the institutions.